Subscribe
Israel-Hamas Conflict
US Politics
Republican Party
Halloween
Hurricanes
Donald Trump
US Economy
Election Day
Fox News
US Presidential Election
Kamala Harris
NFL
US Crime
Published

Alzheimer's drug gets no

Summary by Svenska Dagbladet
The marketing authorization application for lecanemab, a drug for the treatment of Alzheimer's disease, receives a negative recommendation from the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency. This is reported by the Swedish pharmaceutical company Bioarctic in a press release. The drug is based on a discovery by the Swedish researcher La...
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

AlzheimerAlzheimer
Alzheimer's DiseaseAlzheimer's Disease
SwedenSweden

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

Trending Topics
Ground News logo
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal